Johnson & Johnson’s icotrokinra demonstrates superiority in plaque psoriasis trials, setting stage for market disruption

Pallavi Madhiraju- March 9, 2025 0

New clinical trial data from Johnson & Johnson suggests that icotrokinra results could mark a major shift in plaque psoriasis treatment, demonstrating strong efficacy and ... Read More

Q32 Bio’s bempikibart shows signs of a remittive effect in alopecia areata—Here’s what that means

Pallavi Madhiraju- March 9, 2025 0

Q32 Bio Inc. has released promising SIGNAL-AA trial results, shedding new light on the potential of bempikibart clinical data as an innovative alopecia areata treatment. ... Read More

Indero emerges as rebranded Innovaderm, strengthening dermatology and rheumatology clinical research

Pallavi Madhiraju- March 7, 2025 0

Innovaderm Research has officially rebranded as Indero, reflecting its commitment to dermatology and rheumatology clinical trials. The transformation underscores the company’s longstanding expertise in immune-mediated ... Read More

Cosette Pharmaceuticals to acquire Mayne Pharma in $430m deal, strengthening women’s health and dermatology portfolio

Pallavi Madhiraju- February 21, 2025 0

Cosette Pharmaceuticals has announced a definitive agreement to acquire Mayne Pharma Group Limited, a move that will significantly expand its presence in the women’s health ... Read More

Understanding dark circles: Causes, treatments, and prevention

pharmanewsdaily- February 1, 2025 0

Dark circles under the eyes are a common cosmetic concern affecting people of all ages. While they are often associated with aging, where the skin ... Read More

SciBase expands US reach, advancing early melanoma detection with AI-powered technology

Pallavi Madhiraju- January 30, 2025 0

SciBase Holding AB (STO: SCIB), a leader in AI-driven dermatology solutions, has taken a significant step forward in its US expansion strategy by onboarding multiple ... Read More

The science behind shaving preparations: Innovations and essential properties

pharmanewsdaily- January 27, 2025 0

Shaving has been a vital grooming ritual for centuries, evolving from rudimentary tools to sophisticated razors and highly specialised preparations. Central to this process are ... Read More

Blackheads: Causes, treatments, and prevention for clearer skin

pharmanewsdaily- January 18, 2025 0

Blackheads, or open comedones, are among the most common skin concerns, affecting people of all ages. These small, dark spots often appear on the face, ... Read More

The rising impact of Melanoma: Understanding the risks, causes, and advances in treatment

pharmanewsdaily- January 18, 2025 0

Melanoma, a severe form of skin cancer, originates in melanocytes, the pigment-producing cells responsible for skin color. Known for its aggressive nature, melanoma can metastasise ... Read More

New hope for eczema sufferers as FDA approves Eli Lilly’s EBGLYSS

Pallavi Madhiraju- September 14, 2024 0

Eli Lilly and Company (Lilly) has secured approval from the U.S. Food and Drug Administration (FDA) for its new biologic treatment, EBGLYSS (lebrikizumab-lbkz), for moderate-to-severe ... Read More

123410 / 35 Posts